Blood T-cell profiling in metastatic melanoma patients as a marker for response to immune checkpoint inhibitors combined with radiotherapy

alexandrossfakianakis shared this article with you from Inoreader Blood T-cell profiling in metastatic melanoma patients as a marker for response to immune checkpoint inhibitors combined with radiotherapy via radiotheraphy Publication date: Available online 27 June 2022 Source: Radiotherapy and Oncology Author(s): Gishan Ratnayake, Simone Reinwald, Jack Edwards, Nicholas Wong, Di Yu, Rachel Ward, Robin Smith, Andrew Haydon, Pei Au, Menno C. van Zelm, Sashendra Senthi View on Web

Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.